The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
BioFluidica LiquidScan harnesses the power of microfluidics
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
It aims to make the state-of-the-art modern and safe surgical care, typically available in super-speciality hospitals of big cities, accessible, affordable, standardized and integrated
Subscribe To Our Newsletter & Stay Updated
